Uniogen is making real progress in the early detection of ovarian cancer. Our latest study shows that the GLYVAR® Ovarian…

Finnish-developed test helps detect ovarian cancer earlier, improving treatment options and patient outcomes Globally, ovarian cancer is one of the…

In Uniogen’s hometown, Turku, the biotechnology network is tightly connected, fostering strong collaboration between local biotech companies and the university. This…

This February, we join the global community in recognizing World Cancer Day, a time to unite and amplify our commitment…

Advancement in product development, accelerated market entry and exhibitions: In 2024, Uniogen experienced an exceptional year marked by significant progress…

In August the company was accepted into the AMPlify program (an accelerated market entry platform), which is organized in collaboration…

Kaisa Huhtinen, Uniogen´s Oncology Clinical Manager, has a deep understanding of ovarian cancer diagnostics as a PhD and an Associate…

Uniogen has been featured in Finland’s national public broadcasting company news for developing a blood test that could significantly speed…

Uniogen’s cancer diagnostic platform is based on research conducted and published at the University of Turku. Studies show that the…

Uniogen has achieved a remarkable milestone by receiving the esteemed Seal of Excellence from the European Innovation Council (EIC). This…